[HTML][HTML] Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
O Königsbrügge, A Simon, H Domanovits… - BMC cardiovascular …, 2016 - Springer
Background The clinical practice of stroke prevention in atrial fibrillation (AF) with direct oral
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
[PDF][PDF] Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
O Königsbrügge, A Simon, H Domanovits, I Pabinger… - 2017 - cyberleninka.org
Background: The clinical practice of stroke prevention in atrial fibrillation (AF) with direct oral
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
[引用][C] Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
O Königsbrügge, A Simon, H Domanovits… - BMC Cardiovascular …, 2016 - elibrary.ru
Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
O Königsbrügge, A Simon, H Domanovits… - BMC Cardiovascular …, 2016 - infona.pl
Background The clinical practice of stroke prevention in atrial fibrillation (AF) with direct oral
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
[HTML][HTML] Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
O Königsbrügge, A Simon… - BMC …, 2016 - bmccardiovascdisord.biomedcentral …
The clinical practice of stroke prevention in atrial fibrillation (AF) with direct oral
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
O Konigsbrugge, A Simon… - BMC …, 2016 - search.proquest.com
Background The clinical practice of stroke prevention in atrial fibrillation (AF) with direct oral
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
[PDF][PDF] Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
O Königsbrügge, A Simon, H Domanovits, I Pabinger… - 2017 - core.ac.uk
Background: The clinical practice of stroke prevention in atrial fibrillation (AF) with direct oral
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
O Königsbrügge, A Simon, H Domanovits… - BMC Cardiovascular …, 2016 - cdr.lib.unc.edu
Background The clinical practice of stroke prevention in atrial fibrillation (AF) with direct oral
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry.
O Königsbrügge, A Simon, H Domanovits, I Pabinger… - 2016 - cabidigitallibrary.org
Background: The clinical practice of stroke prevention in atrial fibrillation (AF) with direct oral
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry.
O Königsbrügge, A Simon… - BMC …, 2016 - search.ebscohost.com
Background: The clinical practice of stroke prevention in atrial fibrillation (AF) with direct oral
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …
anticoagulants (DOACS) differs from anticoagulation in randomized trial patients. We …